You just read:

Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura

News provided by

Shire plc

Mar 22, 2017, 07:00 ET